Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?

JACC Adv. 2024 Sep 5;3(10):101233. doi: 10.1016/j.jacadv.2024.101233. eCollection 2024 Oct.

Authors

Parag Goyal^{1

2}, Daniel M McDonald¹

Affiliations

¹ Cardiac Amyloidosis Program, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.
² Program for the Care and Study of the Aging Heart, Weill Cornell Medicine, New York, New York, USA.

No abstract available

Keywords: cardiac amyloidosis; heart failure.

Publication types

Editorial